CONMED Corp — Director's Dealing 2016

Jun 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2016-06-03

Reporting Person: POMILIO LUKE A (EVP, Finance & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-03	Common Stock	M	10000	$29.92	Acquired	41884	Direct
2016-06-03	Common Stock	S	4400	$41.5638	Disposed	37484	Direct
2016-06-03	Common Stock	M	10000	$26.69	Acquired	47484	Direct
2016-06-03	Common Stock	F	1794	$41.83	Disposed	45690	Direct
2016-06-03	Common Stock	F	2280	$41.83	Disposed	43410	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-03	Sars (Stock Appreciation Rights)	$29.92	M	10000	Disposed	2017-05-17	Common Stock (10000)	Direct
2016-06-03	Sars (Stock Appreciation Rights)	$26.69	M	10000	Disposed	2018-06-01	Common Stock (10000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.53 to $41.62. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder."

F2: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal
amounts over a five year period.